{"id":"https://openalex.org/W2129588158","doi":"https://doi.org/10.1158/1078-0432.ccr-10-0333","title":"Honokiol Inhibits Epidermal Growth Factor Receptor Signaling and Enhances the Antitumor Effects of Epidermal Growth Factor Receptor Inhibitors","display_name":"Honokiol Inhibits Epidermal Growth Factor Receptor Signaling and Enhances the Antitumor Effects of Epidermal Growth Factor Receptor Inhibitors","publication_year":2010,"publication_date":"2010-04-14","ids":{"openalex":"https://openalex.org/W2129588158","doi":"https://doi.org/10.1158/1078-0432.ccr-10-0333","mag":"2129588158","pmid":"https://pubmed.ncbi.nlm.nih.gov/20388852","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/2871379"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.ccr-10-0333","doi":"https://doi.org/10.1158/1078-0432.ccr-10-0333","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-10-0333","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/2871379","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5042334602","display_name":"Rebecca J. Leeman\u2010Neill","orcid":"https://orcid.org/0000-0003-2921-9885","observed_orcids":["https://orcid.org/0000-0003-2921-9885"]},"institutions":[{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]},{"id":"https://openalex.org/I170201317","display_name":"University of Pittsburgh","ror":"https://ror.org/01an3r305","country_code":"US","type":"education","lineage":["https://openalex.org/I170201317"]},{"id":"https://openalex.org/I4210128526","display_name":"UPMC Hillman Cancer Center","ror":"https://ror.org/03bw34a45","country_code":"US","type":"facility","lineage":["https://openalex.org/I170201317","https://openalex.org/I4210128526"]},{"id":"https://openalex.org/I74973139","display_name":"Carnegie Mellon University","ror":"https://ror.org/05x2bcf33","country_code":"US","type":"education","lineage":["https://openalex.org/I74973139"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rebecca J. Leeman-Neill","raw_affiliation_strings":["Authors' Affiliations: Departments of 1Pathology, 2Otolaryngology, and 3Pharmacology, University of Pittsburgh and University of Pittsburgh Cancer Institute, and 4Heinz College, School of Public Policy and Management, Carnegie Mellon University, Pittsburgh, Pennsylvania; and 5Department of Dermatology, Emory University, Atlanta, Georgia","Department of Dermatology, Emory University, Atlanta, Georgia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations: Departments of 1Pathology, 2Otolaryngology, and 3Pharmacology, University of Pittsburgh and University of Pittsburgh Cancer Institute, and 4Heinz College, School of Public Policy and Management, Carnegie Mellon University, Pittsburgh, Pennsylvania; and 5Department of Dermatology, Emory University, Atlanta, Georgia","institution_ids":["https://openalex.org/I150468666","https://openalex.org/I170201317","https://openalex.org/I4210128526","https://openalex.org/I74973139"]},{"raw_affiliation_string":"Department of Dermatology, Emory University, Atlanta, Georgia","institution_ids":["https://openalex.org/I150468666"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Quan Cai","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]},{"id":"https://openalex.org/I170201317","display_name":"University of Pittsburgh","ror":"https://ror.org/01an3r305","country_code":"US","type":"education","lineage":["https://openalex.org/I170201317"]},{"id":"https://openalex.org/I4210128526","display_name":"UPMC Hillman Cancer Center","ror":"https://ror.org/03bw34a45","country_code":"US","type":"facility","lineage":["https://openalex.org/I170201317","https://openalex.org/I4210128526"]},{"id":"https://openalex.org/I74973139","display_name":"Carnegie Mellon University","ror":"https://ror.org/05x2bcf33","country_code":"US","type":"education","lineage":["https://openalex.org/I74973139"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Quan Cai","raw_affiliation_strings":["Authors' Affiliations: Departments of 1Pathology, 2Otolaryngology, and 3Pharmacology, University of Pittsburgh and University of Pittsburgh Cancer Institute, and 4Heinz College, School of Public Policy and Management, Carnegie Mellon University, Pittsburgh, Pennsylvania; and 5Department of Dermatology, Emory University, Atlanta, Georgia","Department of Dermatology, Emory University, Atlanta, Georgia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations: Departments of 1Pathology, 2Otolaryngology, and 3Pharmacology, University of Pittsburgh and University of Pittsburgh Cancer Institute, and 4Heinz College, School of Public Policy and Management, Carnegie Mellon University, Pittsburgh, Pennsylvania; and 5Department of Dermatology, Emory University, Atlanta, Georgia","institution_ids":["https://openalex.org/I150468666","https://openalex.org/I170201317","https://openalex.org/I4210128526","https://openalex.org/I74973139"]},{"raw_affiliation_string":"Department of Dermatology, Emory University, Atlanta, Georgia","institution_ids":["https://openalex.org/I150468666"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039943682","display_name":"Sonali C. Joyce","orcid":"https://orcid.org/0000-0003-4839-825X","observed_orcids":["https://orcid.org/0000-0003-4839-825X"]},"institutions":[{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]},{"id":"https://openalex.org/I170201317","display_name":"University of Pittsburgh","ror":"https://ror.org/01an3r305","country_code":"US","type":"education","lineage":["https://openalex.org/I170201317"]},{"id":"https://openalex.org/I4210128526","display_name":"UPMC Hillman Cancer Center","ror":"https://ror.org/03bw34a45","country_code":"US","type":"facility","lineage":["https://openalex.org/I170201317","https://openalex.org/I4210128526"]},{"id":"https://openalex.org/I74973139","display_name":"Carnegie Mellon University","ror":"https://ror.org/05x2bcf33","country_code":"US","type":"education","lineage":["https://openalex.org/I74973139"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sonali C. Joyce","raw_affiliation_strings":["Authors' Affiliations: Departments of 1Pathology, 2Otolaryngology, and 3Pharmacology, University of Pittsburgh and University of Pittsburgh Cancer Institute, and 4Heinz College, School of Public Policy and Management, Carnegie Mellon University, Pittsburgh, Pennsylvania; and 5Department of Dermatology, Emory University, Atlanta, Georgia","Department of Dermatology, Emory University, Atlanta, Georgia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations: Departments of 1Pathology, 2Otolaryngology, and 3Pharmacology, University of Pittsburgh and University of Pittsburgh Cancer Institute, and 4Heinz College, School of Public Policy and Management, Carnegie Mellon University, Pittsburgh, Pennsylvania; and 5Department of Dermatology, Emory University, Atlanta, Georgia","institution_ids":["https://openalex.org/I150468666","https://openalex.org/I170201317","https://openalex.org/I4210128526","https://openalex.org/I74973139"]},{"raw_affiliation_string":"Department of Dermatology, Emory University, Atlanta, Georgia","institution_ids":["https://openalex.org/I150468666"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066378974","display_name":"Sufi Mary Thomas","orcid":"https://orcid.org/0000-0001-5370-0842","observed_orcids":["https://orcid.org/0000-0001-5370-0842"]},"institutions":[{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]},{"id":"https://openalex.org/I170201317","display_name":"University of Pittsburgh","ror":"https://ror.org/01an3r305","country_code":"US","type":"education","lineage":["https://openalex.org/I170201317"]},{"id":"https://openalex.org/I4210128526","display_name":"UPMC Hillman Cancer Center","ror":"https://ror.org/03bw34a45","country_code":"US","type":"facility","lineage":["https://openalex.org/I170201317","https://openalex.org/I4210128526"]},{"id":"https://openalex.org/I74973139","display_name":"Carnegie Mellon University","ror":"https://ror.org/05x2bcf33","country_code":"US","type":"education","lineage":["https://openalex.org/I74973139"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sufi M. Thomas","raw_affiliation_strings":["Authors' Affiliations: Departments of 1Pathology, 2Otolaryngology, and 3Pharmacology, University of Pittsburgh and University of Pittsburgh Cancer Institute, and 4Heinz College, School of Public Policy and Management, Carnegie Mellon University, Pittsburgh, Pennsylvania; and 5Department of Dermatology, Emory University, Atlanta, Georgia","Department of Dermatology, Emory University, Atlanta, Georgia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations: Departments of 1Pathology, 2Otolaryngology, and 3Pharmacology, University of Pittsburgh and University of Pittsburgh Cancer Institute, and 4Heinz College, School of Public Policy and Management, Carnegie Mellon University, Pittsburgh, Pennsylvania; and 5Department of Dermatology, Emory University, Atlanta, Georgia","institution_ids":["https://openalex.org/I150468666","https://openalex.org/I170201317","https://openalex.org/I4210128526","https://openalex.org/I74973139"]},{"raw_affiliation_string":"Department of Dermatology, Emory University, Atlanta, Georgia","institution_ids":["https://openalex.org/I150468666"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008062526","display_name":"Neil E. Bhola","orcid":"https://orcid.org/0000-0003-3192-7514","observed_orcids":["https://orcid.org/0000-0003-3192-7514"]},"institutions":[{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]},{"id":"https://openalex.org/I170201317","display_name":"University of Pittsburgh","ror":"https://ror.org/01an3r305","country_code":"US","type":"education","lineage":["https://openalex.org/I170201317"]},{"id":"https://openalex.org/I4210128526","display_name":"UPMC Hillman Cancer Center","ror":"https://ror.org/03bw34a45","country_code":"US","type":"facility","lineage":["https://openalex.org/I170201317","https://openalex.org/I4210128526"]},{"id":"https://openalex.org/I74973139","display_name":"Carnegie Mellon University","ror":"https://ror.org/05x2bcf33","country_code":"US","type":"education","lineage":["https://openalex.org/I74973139"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Neil E. Bhola","raw_affiliation_strings":["Authors' Affiliations: Departments of 1Pathology, 2Otolaryngology, and 3Pharmacology, University of Pittsburgh and University of Pittsburgh Cancer Institute, and 4Heinz College, School of Public Policy and Management, Carnegie Mellon University, Pittsburgh, Pennsylvania; and 5Department of Dermatology, Emory University, Atlanta, Georgia","Department of Dermatology, Emory University, Atlanta, Georgia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations: Departments of 1Pathology, 2Otolaryngology, and 3Pharmacology, University of Pittsburgh and University of Pittsburgh Cancer Institute, and 4Heinz College, School of Public Policy and Management, Carnegie Mellon University, Pittsburgh, Pennsylvania; and 5Department of Dermatology, Emory University, Atlanta, Georgia","institution_ids":["https://openalex.org/I150468666","https://openalex.org/I170201317","https://openalex.org/I4210128526","https://openalex.org/I74973139"]},{"raw_affiliation_string":"Department of Dermatology, Emory University, Atlanta, Georgia","institution_ids":["https://openalex.org/I150468666"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067772128","display_name":"Daniel B. Neill","orcid":"https://orcid.org/0000-0001-6282-1240","observed_orcids":["https://orcid.org/0000-0001-6282-1240"]},"institutions":[{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]},{"id":"https://openalex.org/I170201317","display_name":"University of Pittsburgh","ror":"https://ror.org/01an3r305","country_code":"US","type":"education","lineage":["https://openalex.org/I170201317"]},{"id":"https://openalex.org/I4210128526","display_name":"UPMC Hillman Cancer Center","ror":"https://ror.org/03bw34a45","country_code":"US","type":"facility","lineage":["https://openalex.org/I170201317","https://openalex.org/I4210128526"]},{"id":"https://openalex.org/I74973139","display_name":"Carnegie Mellon University","ror":"https://ror.org/05x2bcf33","country_code":"US","type":"education","lineage":["https://openalex.org/I74973139"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel B. Neill","raw_affiliation_strings":["Authors' Affiliations: Departments of 1Pathology, 2Otolaryngology, and 3Pharmacology, University of Pittsburgh and University of Pittsburgh Cancer Institute, and 4Heinz College, School of Public Policy and Management, Carnegie Mellon University, Pittsburgh, Pennsylvania; and 5Department of Dermatology, Emory University, Atlanta, Georgia","Department of Dermatology, Emory University, Atlanta, Georgia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations: Departments of 1Pathology, 2Otolaryngology, and 3Pharmacology, University of Pittsburgh and University of Pittsburgh Cancer Institute, and 4Heinz College, School of Public Policy and Management, Carnegie Mellon University, Pittsburgh, Pennsylvania; and 5Department of Dermatology, Emory University, Atlanta, Georgia","institution_ids":["https://openalex.org/I150468666","https://openalex.org/I170201317","https://openalex.org/I4210128526","https://openalex.org/I74973139"]},{"raw_affiliation_string":"Department of Dermatology, Emory University, Atlanta, Georgia","institution_ids":["https://openalex.org/I150468666"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004887935","display_name":"Jack L. Arbiser","orcid":"https://orcid.org/0000-0002-6798-6383","observed_orcids":["https://orcid.org/0000-0002-6798-6383"]},"institutions":[{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]},{"id":"https://openalex.org/I170201317","display_name":"University of Pittsburgh","ror":"https://ror.org/01an3r305","country_code":"US","type":"education","lineage":["https://openalex.org/I170201317"]},{"id":"https://openalex.org/I4210128526","display_name":"UPMC Hillman Cancer Center","ror":"https://ror.org/03bw34a45","country_code":"US","type":"facility","lineage":["https://openalex.org/I170201317","https://openalex.org/I4210128526"]},{"id":"https://openalex.org/I74973139","display_name":"Carnegie Mellon University","ror":"https://ror.org/05x2bcf33","country_code":"US","type":"education","lineage":["https://openalex.org/I74973139"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jack L. Arbiser","raw_affiliation_strings":["Authors' Affiliations: Departments of 1Pathology, 2Otolaryngology, and 3Pharmacology, University of Pittsburgh and University of Pittsburgh Cancer Institute, and 4Heinz College, School of Public Policy and Management, Carnegie Mellon University, Pittsburgh, Pennsylvania; and 5Department of Dermatology, Emory University, Atlanta, Georgia","Department of Dermatology, Emory University, Atlanta, Georgia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations: Departments of 1Pathology, 2Otolaryngology, and 3Pharmacology, University of Pittsburgh and University of Pittsburgh Cancer Institute, and 4Heinz College, School of Public Policy and Management, Carnegie Mellon University, Pittsburgh, Pennsylvania; and 5Department of Dermatology, Emory University, Atlanta, Georgia","institution_ids":["https://openalex.org/I150468666","https://openalex.org/I170201317","https://openalex.org/I4210128526","https://openalex.org/I74973139"]},{"raw_affiliation_string":"Department of Dermatology, Emory University, Atlanta, Georgia","institution_ids":["https://openalex.org/I150468666"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5107277424","display_name":"Jennifer Rubin Grandis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]},{"id":"https://openalex.org/I170201317","display_name":"University of Pittsburgh","ror":"https://ror.org/01an3r305","country_code":"US","type":"education","lineage":["https://openalex.org/I170201317"]},{"id":"https://openalex.org/I4210128526","display_name":"UPMC Hillman Cancer Center","ror":"https://ror.org/03bw34a45","country_code":"US","type":"facility","lineage":["https://openalex.org/I170201317","https://openalex.org/I4210128526"]},{"id":"https://openalex.org/I74973139","display_name":"Carnegie Mellon University","ror":"https://ror.org/05x2bcf33","country_code":"US","type":"education","lineage":["https://openalex.org/I74973139"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Jennifer R. Grandis","raw_affiliation_strings":["Authors' Affiliations: Departments of 1Pathology, 2Otolaryngology, and 3Pharmacology, University of Pittsburgh and University of Pittsburgh Cancer Institute, and 4Heinz College, School of Public Policy and Management, Carnegie Mellon University, Pittsburgh, Pennsylvania; and 5Department of Dermatology, Emory University, Atlanta, Georgia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations: Departments of 1Pathology, 2Otolaryngology, and 3Pharmacology, University of Pittsburgh and University of Pittsburgh Cancer Institute, and 4Heinz College, School of Public Policy and Management, Carnegie Mellon University, Pittsburgh, Pennsylvania; and 5Department of Dermatology, Emory University, Atlanta, Georgia","institution_ids":["https://openalex.org/I150468666","https://openalex.org/I170201317","https://openalex.org/I4210128526","https://openalex.org/I74973139"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5107277424"],"corresponding_institution_ids":["https://openalex.org/I150468666","https://openalex.org/I170201317","https://openalex.org/I4210128526","https://openalex.org/I74973139"],"apc_list":null,"apc_paid":null,"fwci":6.9843,"has_fulltext":false,"cited_by_count":106,"citation_normalized_percentile":{"value":0.96908355,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":94,"max":99},"biblio":{"volume":"16","issue":"9","first_page":"2571","last_page":"2579"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T13677","display_name":"Magnolia and Illicium research","score":0.9272000193595886,"subfield":{"id":"https://openalex.org/subfields/2742","display_name":"Rehabilitation"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T13677","display_name":"Magnolia and Illicium research","score":0.9272000193595886,"subfield":{"id":"https://openalex.org/subfields/2742","display_name":"Rehabilitation"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10307","display_name":"Head and Neck Cancer Studies","score":0.02800000086426735,"subfield":{"id":"https://openalex.org/subfields/2733","display_name":"Otorhinolaryngology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.014399999752640724,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/honokiol","display_name":"honokiol","score":1.0},{"id":"https://openalex.org/keywords/epidermal-growth-factor-receptor","display_name":"epidermal growth factor receptor","score":0.9399999976158142},{"id":"https://openalex.org/keywords/head-and-neck-squamous-cell-carcinoma","display_name":"head and neck squamous cell carcinoma","score":0.9869999885559082},{"id":"https://openalex.org/keywords/egfr-inhibitors","display_name":"EGFR inhibitors","score":0.9350000023841858},{"id":"https://openalex.org/keywords/erlotinib","display_name":"erlotinib","score":0.8500000238418579},{"id":"https://openalex.org/keywords/cetuximab","display_name":"cetuximab","score":0.9990000128746033},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.7910000085830688},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.6809999942779541},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.6340000033378601},{"id":"https://openalex.org/keywords/stat3-signaling","display_name":"STAT3 signaling","score":0.7699999809265137},{"id":"https://openalex.org/keywords/akt-signaling","display_name":"Akt signaling","score":0.8709999918937683},{"id":"https://openalex.org/keywords/mapk-signaling","display_name":"MAPK signaling","score":0.968999981880188},{"id":"https://openalex.org/keywords/bcl-xl","display_name":"Bcl-xL","score":0.8629999756813049},{"id":"https://openalex.org/keywords/cyclin-d1","display_name":"cyclin D1","score":0.9900000095367432},{"id":"https://openalex.org/keywords/natural-compounds","display_name":"natural compounds","score":0.37700000405311584}],"concepts":[{"id":"https://openalex.org/C2781334404","wikidata":"https://www.wikidata.org/wiki/Q5896650","display_name":"Honokiol","level":2,"score":0.9047402739524841},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.7422018647193909},{"id":"https://openalex.org/C2778087573","wikidata":"https://www.wikidata.org/wiki/Q418369","display_name":"Erlotinib","level":4,"score":0.7185910940170288},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6029934287071228},{"id":"https://openalex.org/C2777506169","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"EGFR inhibitors","level":4,"score":0.5819342732429504},{"id":"https://openalex.org/C2779707156","wikidata":"https://www.wikidata.org/wiki/Q5611758","display_name":"Growth inhibition","level":3,"score":0.579725980758667},{"id":"https://openalex.org/C2776833033","wikidata":"https://www.wikidata.org/wiki/Q1783924","display_name":"Head and neck squamous-cell carcinoma","level":4,"score":0.5319198966026306},{"id":"https://openalex.org/C2909325608","wikidata":"https://www.wikidata.org/wiki/Q418369","display_name":"Erlotinib Hydrochloride","level":5,"score":0.4638388752937317},{"id":"https://openalex.org/C2776362946","wikidata":"https://www.wikidata.org/wiki/Q424374","display_name":"Epidermal growth factor","level":3,"score":0.44203096628189087},{"id":"https://openalex.org/C75217442","wikidata":"https://www.wikidata.org/wiki/Q423650","display_name":"Protein kinase B","level":3,"score":0.4408632218837738},{"id":"https://openalex.org/C26375932","wikidata":"https://www.wikidata.org/wiki/Q118226","display_name":"Growth factor receptor","level":3,"score":0.4352061152458191},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4122135639190674},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.3830328583717346},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.34401118755340576},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2981492280960083},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.2635350227355957},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.23555049300193787},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.15182864665985107},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.14025932550430298},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.09095600247383118},{"id":"https://openalex.org/C2776530083","wikidata":"https://www.wikidata.org/wiki/Q1783924","display_name":"Head and neck cancer","level":3,"score":0.07019910216331482},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000068818","descriptor_name":"Cetuximab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000069347","descriptor_name":"Erlotinib Hydrochloride","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000498","descriptor_name":"Allyl Compounds","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000972","descriptor_name":"Antineoplastic Agents, Phytogenic","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000972","descriptor_name":"Antineoplastic Agents, Phytogenic","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D001713","descriptor_name":"Biphenyl Compounds","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D001713","descriptor_name":"Biphenyl Compounds","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D002294","descriptor_name":"Carcinoma, Squamous Cell","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D002294","descriptor_name":"Carcinoma, Squamous Cell","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D002294","descriptor_name":"Carcinoma, Squamous Cell","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D002470","descriptor_name":"Cell Survival","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004357","descriptor_name":"Drug Synergism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004365","descriptor_name":"Drugs, Chinese Herbal","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004365","descriptor_name":"Drugs, Chinese Herbal","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D006258","descriptor_name":"Head and Neck Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D006258","descriptor_name":"Head and Neck Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006258","descriptor_name":"Head and Neck Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008819","descriptor_name":"Mice, Nude","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010636","descriptor_name":"Phenols","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011799","descriptor_name":"Quinazolines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011799","descriptor_name":"Quinazolines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D015153","descriptor_name":"Blotting, Western","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015398","descriptor_name":"Signal Transduction","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D017705","descriptor_name":"Lignans","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D017705","descriptor_name":"Lignans","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D023041","descriptor_name":"Xenograft Model Antitumor Assays","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D049109","descriptor_name":"Cell Proliferation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D066246","descriptor_name":"ErbB Receptors","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D066246","descriptor_name":"ErbB Receptors","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1158/1078-0432.ccr-10-0333","doi":"https://doi.org/10.1158/1078-0432.ccr-10-0333","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-10-0333","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},{"id":"pmid:20388852","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20388852","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:2871379","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/2871379","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Clin Cancer Res","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:2871379","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/2871379","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Clin Cancer Res","raw_type":"Text"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9763000011444092,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G4237613962","display_name":"Stat3 as a Therapeutic Target in Head and Neck Cancer","funder_award_id":"R01CA101840","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G4810406548","display_name":"Prevention of Head and Neck Carcinogenesis with a Plant-Derived Compound","funder_award_id":"F30ES015669","funder_id":"https://openalex.org/F4320337361","funder_display_name":"National Institute of Environmental Health Sciences"},{"id":"https://openalex.org/G9000895320","display_name":"Head and Neck Cancer SPORE","funder_award_id":"P50CA097190","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"},{"id":"https://openalex.org/F4320337361","display_name":"National Institute of Environmental Health Sciences","ror":"https://ror.org/00j4k1h63"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":53,"referenced_works":["https://openalex.org/W1532527807","https://openalex.org/W1584223654","https://openalex.org/W1838340609","https://openalex.org/W1907000598","https://openalex.org/W1964068675","https://openalex.org/W1965450084","https://openalex.org/W1972475208","https://openalex.org/W1972699527","https://openalex.org/W1974992652","https://openalex.org/W1979955228","https://openalex.org/W1981895882","https://openalex.org/W1982785575","https://openalex.org/W1988725623","https://openalex.org/W1995513775","https://openalex.org/W1999125418","https://openalex.org/W2004911329","https://openalex.org/W2005204942","https://openalex.org/W2012558233","https://openalex.org/W2015309828","https://openalex.org/W2030611702","https://openalex.org/W2036363901","https://openalex.org/W2038990793","https://openalex.org/W2043061500","https://openalex.org/W2044485209","https://openalex.org/W2044991100","https://openalex.org/W2047670432","https://openalex.org/W2052276044","https://openalex.org/W2055333644","https://openalex.org/W2061446835","https://openalex.org/W2062057316","https://openalex.org/W2066789693","https://openalex.org/W2067178867","https://openalex.org/W2071900493","https://openalex.org/W2082007973","https://openalex.org/W2083215308","https://openalex.org/W2090122242","https://openalex.org/W2099792017","https://openalex.org/W2099854686","https://openalex.org/W2101450339","https://openalex.org/W2104174197","https://openalex.org/W2106265598","https://openalex.org/W2121771461","https://openalex.org/W2147191052","https://openalex.org/W2147353530","https://openalex.org/W2149447281","https://openalex.org/W2154177487","https://openalex.org/W2157946848","https://openalex.org/W2170758581","https://openalex.org/W2188430162","https://openalex.org/W2315613727","https://openalex.org/W6634886735","https://openalex.org/W6639860694","https://openalex.org/W6675174945"],"related_works":["https://openalex.org/W2147084722","https://openalex.org/W2766465189","https://openalex.org/W2481421684","https://openalex.org/W2316391673","https://openalex.org/W2806695869","https://openalex.org/W2015309828","https://openalex.org/W2073943339","https://openalex.org/W7100955371","https://openalex.org/W2767613276","https://openalex.org/W3030485216"],"abstract_inverted_index":{"PURPOSE:":[0],"This":[1],"study":[2],"aimed":[3],"to":[4,30,45,68,79,96,100,202,206],"investigate":[5],"the":[6,15,32,47,60,70,148,155,177,207,232],"utility":[7],"of":[8,17,49,64,72,115,121,131,137,154,168,179,211,234],"honokiol,":[9],"a":[10,38,183],"naturally":[11],"occurring":[12],"compound,":[13],"in":[14,42,82,169,225,227],"treatment":[16,175],"head":[18],"and":[19,44,59,99,126,129,135,142,151,185,237],"neck":[20],"squamous":[21],"cell":[22,57,85],"carcinoma":[23],"(HNSCC)":[24],"as":[25,27,103],"well":[26],"its":[28],"ability":[29],"target":[31,41,139],"epidermal":[33],"growth":[34,81,149,172,195,208],"factor":[35],"receptor":[36],"(EGFR),":[37],"critical":[39],"therapeutic":[40,223],"HNSCC,":[43,226],"enhance":[46],"effects":[48,71,110,210,233],"other":[50],"EGFR-targeting":[51,156],"therapies.":[52],"EXPERIMENTAL":[53],"DESIGN:":[54],"Human":[55],"HNSCC":[56,65,84,160,198],"lines":[58],"xenograft":[61,161],"animal":[62],"model":[63],"were":[66,111],"used":[67],"test":[69],"honokiol":[73,146,174,180,218],"treatment.":[74],"RESULTS:":[75],"Honokiol":[76],"was":[77],"found":[78],"inhibit":[80],"human":[83],"lines,":[86],"with":[87,113,173],"50%":[88],"effective":[89,222],"concentration":[90],"(EC(50))":[91],"values":[92],"ranging":[93],"from":[94],"3.3":[95],"7.4":[97],"micromol/L,":[98],"induce":[101],"apoptosis,":[102],"shown":[104],"through":[105],"Annexin":[106],"V":[107],"staining.":[108],"These":[109,214],"associated":[112],"inhibition":[114,120,167],"EGFR":[116,188,235],"signaling,":[117],"including":[118],"downstream":[119],"mitogen-activated":[122],"protein":[123],"kinase,":[124],"Akt,":[125],"signal":[127],"transducer":[128],"activator":[130],"transcription":[132],"3":[133],"(STAT3),":[134],"expression":[136],"STAT3":[138],"genes,":[140],"Bcl-X(L)":[141],"cyclin":[143],"D1.":[144],"Furthermore,":[145],"enhanced":[147,194],"inhibitory":[150,209],"anti-invasion":[152],"activity":[153],"agent":[157,224],"erlotinib.":[158],"Although":[159],"models":[162],"did":[163],"not":[164],"show":[165],"significant":[166],"vivo":[170],"tumor":[171],"alone,":[176],"combination":[178],"plus":[181],"cetuximab,":[182],"Food":[184],"Drug":[186],"Administration-approved":[187],"inhibitor":[189],"for":[190],"this":[191],"malignancy,":[192],"significantly":[193],"inhibition.":[196],"Finally,":[197],"cells":[199],"rendered":[200],"resistant":[201],"erlotinib":[203],"retained":[204],"sensitivity":[205],"honokiol.":[212],"CONCLUSIONS:":[213],"results":[215],"suggest":[216],"that":[217],"may":[219],"be":[220],"an":[221],"which":[228],"it":[229],"can":[230],"augment":[231],"inhibitors":[236],"overcome":[238],"drug":[239],"resistance.":[240]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":10},{"year":2021,"cited_by_count":9},{"year":2020,"cited_by_count":10},{"year":2019,"cited_by_count":8},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":11},{"year":2016,"cited_by_count":10},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":8},{"year":2012,"cited_by_count":7}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}